Johnson & Johnson (LON:0R34)

London flag London · Delayed Price · Currency is GBP · Price in USD
202.15
-0.54 (-0.27%)
At close: Dec 5, 2025
33.87%
Market Cap 365.15B
Revenue (ttm) 68.71B
Net Income (ttm) 18.73B
Shares Out n/a
EPS (ttm) 7.72
PE Ratio 19.49
Forward PE 18.00
Dividend 3.89 (1.93%)
Ex-Dividend Date Nov 25, 2025
Volume 3,504
Average Volume 29,713
Open 202.25
Previous Close 202.70
Day's Range 200.80 - 203.50
52-Week Range 138.04 - 210.00
Beta n/a
RSI 58.71
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R34
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.